BioCentury
ARTICLE | Emerging Company Profile

Affomix: Whole proteome arrays

May 25, 2009 7:00 AM UTC

Antibody arrays are a more accurate tool for measuring protein levels in biological samples than commonly used mRNA-based methods. But the cost and time needed to generate antibodies has limited the space that can be covered to a few protein families.

Affomix Corp. has developed an automated yeast hybrid antibody screening technology that it believes will cut time and cost enough to develop a whole proteome antibody array...